Modulatory effects of marine algae-derived natural products on nervous system
Related Experiment Video
Updated: Nov 2, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Qihui Huang1, Weihao Wu2, Junjie Fu3
1College of Food and Health, Zhejiang A&F University, No. 666 Wusu street, Hangzhou 311300, China; Universidade de Vigo, Nutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Instituto de Agroecoloxía e Alimentación (IAA)-CITEXVI, 36310 Vigo, Spain.
Background:
The pathological changes in neurodegenerative diseases are complicated and involve oxidative stress, neuroinflammation, protein misfolding, and synaptic loss. Marine algae contain a wide range of diverse natural compounds, such as polysaccharides, phenolics, terpenoids, and pigments, some of which may help preserve neurons by targeting oxidative pathways, dampening inflammatory responses, and preventing toxic protein aggregation.
Purpose:
This review aims to recapitulate current advances on the regulatory roles of marine algae-derived natural products on nervous system. In addition, representative compounds are discussed, together with the relationship between their structures and neuroprotective properties.
Methods:
To conduct this structured narrative review, we collected relevant literature obtained from PubMed, Web of Science, Scopus, and Google Scholar up to June 2026. Relevant studies on the effect of algal products on neuroprotection were selected and articles were searched using terms that covered marine algae, natural products, neurodegenerative diseases, and structure-activity relationship.
Results:
Natural products found in marine algae may support neuronal protection through the modulation of redox balance, inflammatory signaling, and proteostasis. Their neuroprotective activities are closely associated with structural determinants, and are intrinsically shaped by characteristics like sulfation degree, molecular weight, hydroxyl groups, and conjugated systems.
Conclusion:
This article underscores the potential of these products for neuroprotective interventions, and further studies are warranted to clarify their bioavailability and clinical efficacy.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
16:16Membrane Potentials, Synaptic Responses, Neuronal Circuitry, Neuromodulation and Muscle Histology Using the Crayfish: Student Laboratory Exercises
Published on: January 18, 2011
Related Concept Videos
Neurotransmitters
Neurotransmitters
Gut-Brain Axis
Neurochemical Transmission: Sites of Drug Action
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...